BioPharma, Startups Takeda, Astellas & Sumitomo Mitsui Form Joint Venture to Lift Japanese Innovation From ‘Valley of Death’ By Frank Vinluan
MedCity Influencers Protecting Health Data Without Harming Patients: Overcoming the Barriers That Limit Our Access to Our Personal Health Information By Michael Dershem
MedCity Influencers Vitality in the Supply Chain: The Limitless Potential of ATMPs By Rohin K. Iyer and Robert Brackner
MedCity Influencers Required: A Commitment to Funding State Child Psychiatry Access Programs By Jesse Schnall
MedCity Influencers, Artificial Intelligence Mitotic Counting Reimagined: When AI Meets the Microscope By Juan Antonio Retamero
BioPharma, Pharma Sanofi Commits $1.7B to Buy an Entire Company, But Wants Just a Single Drug By Frank Vinluan
BioPharma, Pharma FDA Issues Alert to Mitigate Risks to a Widely Used Allergy, Nausea Drug By Frank Vinluan
Health Tech MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Jeff Smith, CEO of Bamboo Health By
BioPharma, Artificial Intelligence, Health Tech FDA Forms New Digital Health Advisory Committee to Cover Growing Role of Tech By Frank Vinluan
MedCity Influencers, BioPharma 3 Steps Drug Manufacturers Can Take To Mitigate Revenue Loss From Drug Rebate Noncompliance By Micah Litow
Artificial Intelligence, BioPharma Sumitomo Schizophrenia Drug Discovered With AI Tech Fails in Two Phase 3 Trials By Frank Vinluan
